DCC-2036 M10095
The add to cart button will appear once you select the values above
Specifications
| inquiry |
CAS Number:
1020172-07-9
Target:
Bcr-Abl
Molecular formula:
C30H28FN7O3
Formula weight:
553,5869
Purity:
>98% (HPLC)
Stability:
≥ 2 years
Product description:
DCC-2036 (Rebastinib) is a highly potent, non-ATP-competitive BCR-ABL1 inhibitor with IC50 of 0.8 and 4 nM for native ABL1 and gatekeeper mutant ABL1 T315I, respectively.
Note:
Research use only, not for human use.
More info:
Email info@sobekbio.com
Orders:
Email orders@sobekbio.com